Pmgc holdings inc ELAB.US Overview Analysis

US StockHealth Care
(No presentation for ELAB)

ELAB AI Analysis Overview

Keys for Bullish View

  • Value≥4
  • Dividend≥2

Analysis Conclusion

With insufficient quarterly financial data released by the company, we're unable to provide a rating.

ELAB Current Performance

1.28%

Pmgc holdings inc

0.38%

Avg of Sector

-0.07%

S&P500

Top 10 High Relevance to ELAB

  • YI 111 inc - adr
    Value 2Trend 2Swing Trading 2Whale Interest 1Dividend 1
    See more

ELAB Profile

PMGC Holdings Inc Formerly known as Elevai Labs Inc.. PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The Company's portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.

Price of ELAB